SCHEMBL24876174

SCHEMBL24876174

CCc1ccc(NS(=O)(=O)c2cc3[nH]c(=O)c(=O)[nH]c3cc2C)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 1.00
▸ KMT2A Q03164 1/20 1.00
▸ LMNA P02545 5/20 0.65
▸ PKM P14618 6/20 0.65
▸ POLB P06746 2/20 0.60
▸ GPR55 Q9Y2T6 1/20 0.60
▸ THRB P10828 2/20 0.59
▸ GAA P10253 2/20 0.57
▸ ALDH1A1 P00352 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ IDH1 O75874 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24876302 0.90 MEN1 (0.81) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876742 0.86 PKM (0.76) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876741 0.84 LMNA (0.76) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876169 0.84 MEN1 (0.72) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876039 0.84 MEN1 (0.72) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876051 0.83 PKM (0.71) MEN1KMT2ALMNAPKMPOLB
SCHEMBL31679904 0.83 PKM (0.71) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876017 0.83 MEN1 (0.70) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876241 0.82 LMNA (0.78) MEN1KMT2ALMNAPKMPOLB
SCHEMBL24876755 0.82 MEN1 (0.69) MEN1KMT2ALMNAPKMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367103-B1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-09-03 — — EP disclosed
WO-2023280970-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-01-12 — — WO disclosed
Send feedback